Why the study?
Does fosinopril reduce ADP-induced platelet aggregation in male hypertensive patients?
Population
18 male hypertensive patients
Design
Cohort
Follow-up
4 weeks
Authors
Loading...
May suggest pleiotropic antiplatelet effects in hypertension; hypothesis-generating and should not change practice.
Does fosinopril reduce ADP-induced platelet aggregation in male hypertensive patients?
Fosinopril demonstrates significant inhibitory activity on ADP-induced platelet aggregation in hypertensive patients, suggesting potential pleiotropic anti-atherosclerotic effects.
Keidar et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: